Lv1
80 积分 2024-08-07 加入
Clinicopathologic Characteristics and Follow-Up Outcomes of Invasive Breast Carcinoma With Different Positive HER2 Fluorescence In Situ Hybridization Patterns: Experience From a Single Academic Institution
16天前
已完结
Implications of cancer evolution for drug development
20天前
已完结
Intratumor Heterogeneity and Branched Evolution
20天前
已完结
Hyper-recombination and genetic instability in BLM-deficient epithelial cells
20天前
已关闭
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer
25天前
已完结
Harnessing big data to characterize immune-related adverse events
1个月前
已完结
Germline CDH1 Variants and Lifetime Cancer Risk
2个月前
已完结
Resistance mechanisms and therapeutic strategies of CDK4 and CDK6 kinase targeting in cancer
2个月前
已完结
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer
2个月前
已完结
皖公网安备34019202002308
